Page last updated: 2024-11-08

3,11-dimethylnonacosanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,11-dimethylnonacosanone: contact courting pheromone in German cockroach [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID205987
SCHEMBL ID591815
MeSH IDM0057368

Synonyms (9)

Synonym
ai3-36735
3,11-dimethylnonacosan-2-one
3,11,-dimethylnonacosan-2-one
3,11-dimethylnonacosanone
53623-10-2
2-nonacosanone, 3,11-dimethyl-
LMFA12000235
SCHEMBL591815
DTXSID00968393

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Using isolated male antennae dosed with synthetic test compounds to assay male behavior, we found that at high doses all four stereoisomers elicited responses from 100% of the males."( Behavioral activity of stereoisomers and a new component of the contact sex pheromone of female German cockroach, Blattella germanica.
Eliyahu, D; Leal, WS; Mori, K; Schal, C; Takikawa, H, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]